Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

595 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and economic analysis of spa therapy in Parkinson's disease.
Brefel-Courbon C, Desboeuf K, Thalamas C, Galitzky M, Senard JM, Rascol O, Montastruc JL. Brefel-Courbon C, et al. Among authors: rascol o. Mov Disord. 2003 May;18(5):578-84. doi: 10.1002/mds.10404. Mov Disord. 2003. PMID: 12722173 Clinical Trial.
Does ageing influence deep brain stimulation outcomes in Parkinson's disease?
Ory-Magne F, Brefel-Courbon C, Simonetta-Moreau M, Fabre N, Lotterie JA, Chaynes P, Berry I, Lazorthes Y, Rascol O. Ory-Magne F, et al. Among authors: rascol o. Mov Disord. 2007 Jul 30;22(10):1457-1463. doi: 10.1002/mds.21547. Mov Disord. 2007. PMID: 17516457 Clinical Trial.
Confinement and sleep deprivation effects on propensity to take risks.
Chaumet G, Taillard J, Sagaspe P, Pagani M, Dinges DF, Pavy-Le-Traon A, Bareille MP, Rascol O, Philip P. Chaumet G, et al. Among authors: rascol o. Aviat Space Environ Med. 2009 Feb;80(2):73-80. doi: 10.3357/asem.2366.2009. Aviat Space Environ Med. 2009. PMID: 19198191 Clinical Trial.
Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.
Köllensperger M, Geser F, Ndayisaba JP, Boesch S, Seppi K, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Abele M, Klockgether T, Yekhlef F, Tison F, Daniels C, Deuschl G, Coelho M, Sampaio C, Bozi M, Quinn N, Schrag A, Mathias CJ, Fowler C, Nilsson CF, Widner H, Schimke N, Oertel W, Del Sorbo F, Albanese A, Pellecchia MT, Barone P, Djaldetti R, Colosimo C, Meco G, Gonzalez-Mandly A, Berciano J, Gurevich T, Giladi N, Galitzky M, Rascol O, Kamm C, Gasser T, Siebert U, Poewe W, Wenning GK; EMSA-SG. Köllensperger M, et al. Among authors: rascol o. Mov Disord. 2010 Nov 15;25(15):2604-12. doi: 10.1002/mds.23192. Mov Disord. 2010. PMID: 20922810
Priorities in Parkinson's disease research.
Meissner WG, Frasier M, Gasser T, Goetz CG, Lozano A, Piccini P, Obeso JA, Rascol O, Schapira A, Voon V, Weiner DM, Tison F, Bezard E. Meissner WG, et al. Among authors: rascol o. Nat Rev Drug Discov. 2011 May;10(5):377-93. doi: 10.1038/nrd3430. Nat Rev Drug Discov. 2011. PMID: 21532567 Review.
595 results